<mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" ID="bdr156" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/mods/v3/mods-3-7.xsd">
  <mods:titleInfo>
    <mods:title>A Creative Gap in the Medical Science Fight Against Diseases of Poverty</mods:title>
  </mods:titleInfo>
  <mods:name type="personal">
    <mods:namePart>Edwards, David</mods:namePart>
    <mods:role>
      <mods:roleTerm authority="marcrelator" type="text">author</mods:roleTerm>
    </mods:role>
  </mods:name>
  <mods:typeOfResource>text</mods:typeOfResource>
  <mods:genre authority="aat">articles</mods:genre>
  <mods:originInfo>
    <mods:dateCreated encoding="w3cdtf" keyDate="yes">2008</mods:dateCreated>
  </mods:originInfo>
  <mods:language usage="primary">
    <mods:languageTerm authority="iso639-2b" type="code">eng</mods:languageTerm>
  </mods:language>
  <mods:physicalDescription>
    <mods:digitalOrigin>born digital</mods:digitalOrigin>
    <mods:extent>pp. 155-164</mods:extent>
  </mods:physicalDescription>
  <mods:relatedItem type="host">
    <mods:titleInfo>
      <mods:title>Brown Journal of World Affairs</mods:title>
    </mods:titleInfo>
    <mods:identifier type="issn">1080-0786</mods:identifier>
    <mods:part>
      <mods:detail type="volume">
        <mods:number>15</mods:number>
        <mods:caption>no.</mods:caption>
      </mods:detail>
      <mods:detail type="issue">
       <mods:number>1</mods:number>
       <mods:caption>no.</mods:caption>
      </mods:detail>
      <mods:extent unit="page">
        <mods:start>155</mods:start>
        <mods:end>164</mods:end>
      </mods:extent>
    </mods:part>
  </mods:relatedItem>
  <mods:abstract lang="eng"> 
 The article explores the absence of a socioeconomic model that translates scientific discoveries to improved patient care for the impoverished, which is one of the arresting realities in the fight against diseases of poverty. Pharmaceutical development occurs in three stages. Basic research is carried out in laboratories and the prospect of economic profit drives entrepreneurs to translate discoveries into clinical treatments. Companies license the products from small organizations and invest to commercialize pharmaceutical supplies. Lowering product risk means early integration of advanced delivery technologies to improve sustainability of drug and vaccine candidates.
  </mods:abstract>
<mods:identifier xmlns:xlink="http://www.w3.org/1999/xlink" type="doi">10.26300/samz-bz21</mods:identifier></mods:mods>